Fibromyalgia-Drug Pipeline Analysis and Market Forecasts to 2015

Oct. 9, 2010 - PRLog -- "Fibromyalgia-Drug Pipeline Analysis and Market Forecasts to 2015" is an essential source of information and analysis on the global fibromyalgia market. The report identifies the key trends shaping and driving the global fibromyalgia market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global fibromyalgia sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis.
Scope
The scope of the report includes:
-Annualized global fibromyalgia market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
-Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
-Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
-Analysis of the current and future market competition in the global fibromyalgia market.
-Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
-Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with fibromyalgia.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
-Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
-Develop business strategies by understanding the trends shaping and driving the global fibromyalgia disease market.
-Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global fibromyalgia disease market in future.
-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
-Identify emerging players with potentially strong product portfolio and create effective   counter-strategies to gain competitive advantage.
-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
-What's the next big thing in the global fibromyalgia disease market landscape? -Identify, understand and capitalize.

Table of Contents
1 Table of contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Fibromyalgia Market: Market Characterization 6
2.1 Overview 6
2.2 Fibromyalgia Market Size 6
2.3 Fibromyalgia Market Forecast and CAGR 7
2.4 Drivers and Barriers for the Fibromyalgia Market 7
2.4.1 Drivers for the Fibromyalgia Market 8
2.4.2 Barriers for the Fibromyalgia Market 8
2.5 Opportunity and Unmet Need 9
2.6 Key Takeaway 10
3 Fibromyalgia Market: Competitive Assessment 11
3.1 Overview 11
3.2 Strategic Competitor Assessment 11
3.3 Product Sales for Major Fibromyalgia Products 12
3.4 Product Profile for the Major Marketed Products in the Fibromyalgia Market 12
3.4.1 Lyrica (Pregabalin) 12
3.4.2 Cymbalta 13
3.4.3 Savella 14
3.5 Key Takeaway 15
4 Fibromyalgia Market: Pipeline Assessment 16
4.1 Overview 16
4.2 Strategic Pipeline Assessment 16
4.2.1 Technology Trends Analytic Framework 16  
4.3 Fibromyalgia Therapeutics-Promising Drugs under Clinical Development 17
4.4 Molecule Profile for Promising Drugs under Clinical Development 17
4.4.1 Xyrem 18
4.4.2 Vimpat (Lacosamide) 18
4.4.3 Droxidopa 19
4.5 Fibromyalgia Therapeutics Market-Clinical Pipeline by Mechanism of Action 19
4.6 Fibromyalgia Pipeline-Pipeline by Clinical Phases of Development 20
4.6.1 Fibromyalgia Therapeutics-Regulatory and Phase III Clinical Pipeline 21
4.6.2 Fibromyalgia Therapeutics-Phase II Clinical Pipeline 21
4.6.3 Fibromyalgia Therapeutics-Phase I Clinical Pipeline 22
4.7 Discontinued/Suspended Drugs for Fibromyalgia 22
4.8 Key Takeaway 23
5 Fibromyalgia Market: Implications for Future Market Competition 24
6 Fibromyalgia Market: Future Players in Fibromyalgia Market 25
6.1 Introduction 25
6.2 Allergan Inc 25
6.2.1 Overview 25
6.2.2 Business Description 26
6.2.3 CNS Disease Therapeutics Portfolio 27
6.3 GlaxoSmithKline 27
6.3.1 Overview 27
6.3.2 CNS Disease Therapeutics Portfolio 29
6.4 Sanofi-Aventis 29
6.4.1 Overview 29
6.4.2 Business Description 29
6.4.3 CNS Disease Therapeutics Portfolio 31
6.5 Chelsea Therapeutics International, Ltd. 31
6.5.1 Overview 31
6.5.2 Business Description 31
6.5.3 CNS Disease Therapeutics Portfolio 32
6.6 UCB 32
6.6.1 Overview 32
6.6.2 Business Description 32
6.6.3 CNS Disease Therapeutics Portfolio 33
7 Fibromyalgia Market: Appendix 34
7.1 Definitions 34
7.2 Acronyms 34
7.2.1 Research Methodology 34
7.2.2 Coverage 35
7.2.3 Secondary Research 35
7.2.4 Forecasting 36
7.2.5 Primary Research 38
7.2.6 Expert Panel Validation 39
7.3 Contact Us 39
7.4 Disclaimer 39
7.5 Sources 39
List of Tables
1.1 List of Tables
Table 1: Global Fibromyalgia Therapeutics Market, Revenue Forecasts ($m), 2000-2008 7
Table 2: Global Fibromyalgia Therapeutics Market, Revenue Forecasts ($m), 2008-2015 7
Table 3: Major Marketed Products Comparison in Fibromyalgia Market , 2009 15
Table 4: Fibromyalgia Therapeutics-Most Promising Drugs under Clinical Development, 2009 17
Table 5: Fibromyalgia Therapeutics-Phase III Clinical Pipeline, 2009 21
Table 6: Fibromyalgia Therapeutics-Phase II Clinical Pipeline, 2009 21
Table 7: Fibromyalgia Therapeutics-Phase I Clinical Pipeline, 2009 22
Table 8: List of Discontinued Drugs for Fibromyalgia, 2009 22
Table 9: Allergan-CNS Diseases Pipeline, 2009 27
Table 10: Allergan-Fybromyalgia Pipeline, 2009 27
Table 11: GlaxoSmithKline-CNS Diseases Pipeline, 2009 29
Table 12: GlaxoSmithKline-Fybromyalgia Pipeline, 2009 29
Table 13: Sanofi-Aventis-CNS Diseases Pipeline, 2009 31
Table 14: Sanofi-Aventis-Fybromyalgia Pipeline, 2009 31
Table 15: Chelsea Therapeutics-CNS Diseases Pipeline, 2009 32
Table 16: Chelsea Therapeutics-Fybromyalgia Pipeline, 2009 32
Table 17: UCB Pharma-CNS Diseases Pipeline, 2009 33
Table 18: UCB Pharma-Fybromyalgia Pipeline, 2009 33
List of Figures
1.2 List of Figures
Figure 1: Global Fibromyalgia Market Forecast 2000-2015, Revenue($m), 2009 7
Figure 2: Opportunity and Unmet Need in the Fibromyalgia Market, 2009 9
Figure 3: Strategic Competitor Assessment of the Major Marketed Products for Fibromyalgia, 2009 11
Figure 4: Global Sales of Top Fibromyalgia Products, 2009 12
Figure 5: Technology Trends Analytic Framework of the Fibromyalgia Pipeline, 2009 16
Figure 6: Technology Trends Analytic Framework of the Fibromyalgia Pipeline-Description, 2009 17
……

# # #

ChinaCCM.com is China's leading industry consultancy expert offering industry intelligence and research solution, ChinaCCM Market Research Centre is a research division focusing on professional market survey and industry research.